B
Bruce Neal
Researcher at The George Institute for Global Health
Publications - 620
Citations - 109123
Bruce Neal is an academic researcher from The George Institute for Global Health. The author has contributed to research in topics: Population & Blood pressure. The author has an hindex of 108, co-authored 561 publications receiving 87213 citations. Previous affiliations of Bruce Neal include National Institutes of Health & University of the Western Cape.
Papers
More filters
Journal ArticleDOI
Salt substitution and salt-supply restriction for lowering blood pressure in elderly care facilities: a cluster-randomized trial
Yifang Yuan,Aoming Jin,Bruce Neal,Xiangxian Feng,Qianku Qiao,Hongxia Wang,Ruijuan Zhang,Jiayu Li,Peifen Duan,Hui Zhang,Senke Hu,Huijuan Li,Pei Gao,Gaoqiang Xie,Jianhui Yuan,Li-Juan Cheng,Haijun Zhang,Wenyi Niu,Hai Fang,Ming-Hui Zhao,Runlin Gao,Junshi Chen,Paul Elliott,Darwin R. Labarthe,Yangfeng Wu +24 more
TL;DR: Wang et al. as discussed by the authors conducted a clinical trial in which 48 residential elderly care facilities in China (1,612 participants including 1,230 men and 382 women, 55 years or older) were cluster-randomized using a 2 × 2 factorial design to provision of salt substitute (62.5% NaCl and 25% KCl) versus usual salt and to a progressively restricted versus usual supply of salt or salt substitute for 2 years.
Journal ArticleDOI
Statistical analysis plan for the Sleep Apnea cardioVascular Endpoints study: An international randomised controlled trial to determine whether continuous positive airways pressure treatment for obstructive sleep apnea in patients with CV disease prevents secondary cardiovascular events
Emma Heeley,Emma Heeley,Laurent Billot,Craig S. Anderson,Craig S. Anderson,Craig S. Anderson,Nick A. Antic,Bruce Neal,Bruce Neal,Bruce Neal,R. Doug McEvoy +10 more
TL;DR: The Sleep Apnea Cardiovascular Endpoints (SAVE) study aims to determine whether CPAP on top of best medical care compared tobest medical care alone can reduce the risk of serious CV events in patients with co-morbid OSA and established CV disease.
Journal ArticleDOI
Estimated Benefits and Risks of Using a Reduced-Sodium, Potassium-Enriched Salt Substitute in India: A Modeling Study
Matti Marklund,Fikru Tullu,Sudhir Raj Thout,Jie Yu,Tammy M. Brady,Lawrence J. Appel,Bruce Neal,Jason H Y Wu,Rachita Gupta +8 more
TL;DR: Modeling nationwide salt substitution in India consistently estimated substantial net benefits, preventing around 8% to 14% of annual cardiovascular deaths and even allowing for potential hyperkalemia risks there were net benefits estimated for individuals with chronic kidney disease.
Journal ArticleDOI
Canagliflozin, serum magnesium and cardiovascular outcomes—Analysis from the CANVAS Program
Katherine M. Wang,Jingwei Li,Jingwei Li,Vivek Bhalla,Meg Jardine,Meg Jardine,Meg Jardine,Bruce Neal,Bruce Neal,Bruce Neal,Dick de Zeeuw,Greg Fulcher,Vlado Perkovic,Vlado Perkovic,Kenneth W. Mahaffey,Tara I. Chang +15 more
TL;DR: This post hoc analysis assesses the relation between serum Mg with cardiovascular outcomes in 10,140 participants of the Canagliflozin Cardiovascular Assessment Study (CANVAS) Program.